Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Pittsburgh › NPI 1841236684
Lab

Quest Diagnostics of Pennsylvania, INC.

Quest Diagnostics of Pennsylvania, INC. was paid $132.39M by Medicaid between Jan 2018 and Dec 2024, across 494 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 15% of everything it billed.

33Billing provider infoQUEST DIAGNOSTICS OF PENNSYLVANIA, INC.
PITTSBURGH, PA 15220
33aNPI1841236684assigned 06/21/2006
33bProvider typeClinical Medical Laboratory
28Total paid$132.39M
24GClaims11,245,781
24DCodes billed494
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Pennsylvania

Rank by total paid#1 of 95
Median peer was paid$153K
This provider vs. median867×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,294,617$11.14M
20191,372,671$13.62M
20201,339,716$21.22M
20211,734,437$26.38M
20221,830,095$23.32M
20232,055,491$20.19M
2024incomplete1,618,754$16.53M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 15% 761,585 454,645 $20.51M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 14% 252,167 204,948 $18.29M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 5.0% 319,571 301,943 $6.56M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 4.8% 316,074 298,520 $6.36M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 4.3% 164,423 112,832 $5.63M
80053 Comprehensive metabolic panel 2.5% 591,021 560,444 $3.28M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2.4% 205,062 198,405 $3.18M
84443 Thyroid stimulating hormone (TSH) 2.2% 376,275 363,607 $2.94M
80061 Lipid panel 2.2% 437,313 423,455 $2.89M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.8% 171,365 161,958 $2.43M
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 1.8% 64,674 61,697 $2.33M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.5% 536,645 505,771 $2.02M
482 more codes
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1.5% 150,221 $1.95M
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1.4% 106,523 $1.79M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1.3% 78,457 $1.76M
86480 1.3% 50,181 $1.71M
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 1.1% 4,690 $1.47M
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1.0% 71,821 $1.34M
81513 <1% 43,389 $1.31M
83036 Hemoglobin; glycosylated (A1C) <1% 253,473 $1.29M
87799 <1% 36,641 $1.25M
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 4,322 $1.20M
80348 <1% 213,722 $1.16M
80050 General health panel <1% 57,508 $1.03M
87086 Culture, bacterial; quantitative colony count, urine <1% 216,839 $1.03M
86803 <1% 129,815 $972K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 9,435 $970K
87902 <1% 7,322 $919K
84439 <1% 181,055 $906K
82607 <1% 113,767 $895K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 13,664 $823K
87088 <1% 146,298 $732K
87522 Neg quan hep c or qual rna <1% 31,420 $728K
87536 <1% 12,949 $644K
86003 <1% 14,299 $589K
80349 <1% 140,508 $584K
80373 <1% 83,791 $564K
84403 <1% 34,565 $516K
80081 <1% 13,463 $508K
80362 <1% 104,733 $505K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 12,994 $499K
82728 <1% 68,074 $497K
84153 <1% 46,122 $467K
87481 <1% 13,668 $462K
36415 Collection of venous blood by venipuncture <1% 499,204 $458K
82746 <1% 65,870 $456K
83655 <1% 59,334 $447K
87512 <1% 22,757 $445K
87340 <1% 75,204 $442K
80354 <1% 96,183 $390K
85027 <1% 111,238 $369K
80355 <1% 104,405 $359K
87081 <1% 90,914 $359K
83550 <1% 78,634 $349K
80321 <1% 70,909 $344K
87070 <1% 68,884 $344K
87186 <1% 65,552 $338K
80048 Basic metabolic panel (calcium, ionized) <1% 73,568 $326K
87077 <1% 63,459 $324K
80074 <1% 18,867 $314K
83540 <1% 88,258 $305K
86769 <1% 8,063 $293K
86235 <1% 8,731 $293K
80360 <1% 39,493 $291K
88142 <1% 19,172 $287K
84702 <1% 35,255 $287K
84402 <1% 18,599 $285K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,654 $282K
80361 <1% 54,278 $275K
80346 <1% 51,587 $273K
88141 <1% 20,281 $265K
80359 <1% 58,269 $262K
81001 <1% 137,910 $262K
83013 <1% 6,602 $258K
86706 <1% 43,902 $254K
86038 <1% 38,121 $250K
86780 <1% 33,899 $250K
86704 <1% 39,591 $248K
86592 <1% 100,701 $235K
83970 <1% 11,448 $235K
86708 <1% 33,691 $230K
86762 <1% 26,672 $226K
83001 <1% 20,434 $225K
82670 <1% 14,242 $224K
84481 <1% 23,102 $219K
82043 <1% 68,293 $214K
84146 <1% 18,315 $207K
82570 <1% 81,794 $204K
80372 <1% 29,634 $194K
86696 <1% 14,957 $188K
86481 <1% 3,113 $187K
86787 <1% 23,130 $186K
81596 <1% 6,207 $184K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 4,842 $183K
87660 <1% 17,140 $182K
80324 <1% 40,275 $180K
80353 <1% 45,593 $178K
87480 <1% 15,036 $176K
87510 <1% 15,028 $175K
87631 <1% 2,381 $166K
83002 <1% 15,405 $164K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,734 $163K
86376 <1% 18,676 $158K
86765 <1% 19,070 $157K
82784 <1% 20,133 $156K
80366 <1% 50,162 $138K
83735 <1% 38,862 $137K
86735 <1% 18,052 $136K
82652 <1% 11,309 $133K
83520 <1% 9,300 $131K
86317 <1% 14,214 $127K
86800 <1% 13,182 $119K
80323 <1% 29,306 $119K
86140 <1% 46,508 $118K
82627 <1% 8,322 $112K
84154 <1% 10,063 $109K
83880 <1% 6,237 $106K
87147 <1% 35,355 $105K
80335 <1% 25,063 $105K
82105 <1% 12,923 $101K
87255 <1% 5,448 $100K
80369 <1% 32,344 $98K
80368 <1% 41,460 $95K
87563 <1% 5,503 $93K
86618 <1% 8,807 $93K
86665 <1% 4,676 $93K
86360 <1% 3,119 $93K
84425 <1% 8,174 $92K
86147 <1% 3,406 $90K
86361 <1% 6,088 $89K
80076 <1% 20,953 $88K
86364 <1% 8,074 $86K
85652 <1% 60,066 $84K
86695 <1% 11,789 $84K
85610 <1% 35,227 $84K
84144 <1% 6,745 $83K
83516 <1% 9,348 $82K
86200 <1% 11,050 $79K
81511 <1% 1,353 $79K
86431 <1% 21,682 $73K
87209 <1% 8,417 $73K
87650 <1% 5,985 $72K
86617 <1% 4,026 $70K
86146 <1% 2,318 $69K
84480 <1% 11,261 $69K
82248 <1% 25,108 $68K
84436 <1% 23,367 $67K
86160 <1% 5,332 $63K
82785 <1% 6,581 $62K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 781 $60K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 878 $59K
86039 <1% 9,575 $59K
87338 <1% 5,782 $59K
82274 <1% 8,014 $57K
86850 <1% 11,424 $57K
84202 <1% 5,931 $56K
87517 <1% 2,504 $56K
84550 <1% 22,338 $55K
83690 <1% 14,979 $55K
83525 <1% 8,109 $54K
82950 <1% 19,643 $54K
84460 <1% 18,072 $53K
87150 <1% 3,102 $53K
88112 <1% 2,208 $53K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 2,194 $52K
84270 <1% 4,341 $51K
86334 <1% 3,949 $49K
81329 <1% 1,146 $48K
87529 <1% 1,349 $48K
80055 <1% 2,049 $46K
82533 <1% 5,042 $46K
83498 <1% 2,945 $46K
80164 <1% 7,025 $45K
80339 <1% 17,629 $44K
86225 <1% 6,007 $44K
86255 <1% 5,580 $44K
86141 <1% 6,156 $43K
83993 <1% 4,186 $43K
82977 <1% 10,880 $43K
82150 <1% 13,128 $43K
80365 <1% 15,236 $40K
84450 <1% 16,517 $40K
87625 <1% 3,080 $40K
84479 <1% 14,983 $39K
86664 <1% 4,041 $39K
87177 <1% 8,422 $39K
84703 <1% 10,716 $38K
83021 <1% 3,131 $38K
87329 <1% 6,685 $38K
83921 <1% 3,551 $38K
83521 <1% 1,425 $37K
87350 <1% 5,792 $37K
82378 <1% 4,007 $37K
80358 <1% 13,289 $36K
86705 <1% 5,530 $36K
86901 <1% 14,595 $36K
82565 <1% 14,342 $35K
82672 <1% 2,692 $35K
87075 <1% 6,196 $35K
84165 <1% 5,964 $34K
82550 <1% 10,019 $34K
84445 <1% 1,270 $34K
82024 <1% 1,493 $34K
86300 <1% 2,829 $34K
82951 <1% 5,724 $33K
84681 <1% 2,614 $32K
85730 <1% 10,282 $32K
86707 <1% 4,943 $32K
83020 <1% 4,336 $31K
86671 <1% 2,203 $28K
87205 <1% 11,162 $26K
86359 <1% 1,256 $26K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 338 $26K
82140 <1% 3,079 $26K
82677 <1% 1,706 $25K
86021 <1% 3,155 $25K
80197 <1% 3,330 $24K
84100 <1% 10,364 $24K
84156 <1% 11,764 $24K
84207 <1% 1,514 $24K
82947 <1% 12,434 $24K
87449 <1% 3,642 $24K
80374 <1% 11,864 $23K
86258 <1% 1,333 $22K
88342 <1% 524 $22K
86900 <1% 12,306 $22K
86381 <1% 1,289 $21K
86008 <1% 1,448 $21K
80178 <1% 6,080 $21K
82330 <1% 3,231 $21K
84630 <1% 3,505 $21K
84520 <1% 11,032 $21K
82088 <1% 896 $20K
86304 <1% 2,022 $20K
80356 <1% 6,162 $19K
86812 <1% 1,547 $19K
86709 <1% 2,837 $19K
82157 <1% 1,103 $18K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 2,717 $18K
83090 <1% 2,039 $18K
80184 <1% 2,657 $18K
86341 <1% 1,213 $18K
83615 <1% 6,323 $18K
81003 <1% 15,171 $18K
80299 <1% 1,009 $18K
87901 <1% 102 $18K
80177 <1% 2,456 $18K
84432 <1% 2,198 $17K
87102 <1% 3,549 $17K
80371 <1% 12,496 $17K
80069 <1% 4,193 $17K
81241 <1% 986 $17K
87427 <1% 2,309 $16K
80345 <1% 5,137 $16K
87324 <1% 2,622 $16K
87800 <1% 703 $16K
86336 <1% 1,801 $15K
82247 <1% 5,299 $15K
81025 <1% 4,179 $14K
86355 <1% 739 $14K
85018 <1% 11,183 $14K
87045 <1% 2,668 $14K
87106 <1% 2,250 $14K
82103 <1% 1,793 $14K
82172 <1% 1,085 $14K
86301 <1% 1,364 $13K
82653 <1% 682 $13K
80320 <1% 4,270 $13K
83721 <1% 4,861 $12K
86593 <1% 4,960 $12K
83010 <1% 1,210 $12K
85060 <1% 1,043 $12K
84305 <1% 1,012 $12K
84155 <1% 6,010 $12K
82542 <1% 1,023 $12K
82390 <1% 1,999 $12K
84075 <1% 4,139 $11K
84466 <1% 1,674 $11K
85014 <1% 8,982 $11K
83883 <1% 942 $11K
86036 <1% 1,224 $11K
86777 <1% 1,280 $11K
80175 <1% 1,442 $10K
87076 <1% 1,725 $10K
86015 <1% 1,420 $10K
82310 <1% 4,642 $10K
82465 <1% 3,786 $10K
82040 <1% 4,587 $10K
84134 <1% 1,456 $10K
86645 <1% 1,049 $10K
82668 <1% 959 $10K
85613 <1% 1,707 $9K
86644 <1% 1,107 $9K
82525 <1% 1,330 $9K
86357 <1% 475 $9K
80051 <1% 2,582 $9K
82626 <1% 630 $9K
84590 <1% 1,271 $9K
85004 <1% 2,454 $9K
82530 <1% 688 $8K
84244 <1% 678 $8K
87506 <1% 81 $8K
83519 <1% 762 $8K
86778 <1% 956 $8K
85045 <1% 4,001 $8K
85041 <1% 4,760 $8K
82164 <1% 870 $8K
84166 <1% 860 $8K
82955 <1% 1,199 $8K
87140 <1% 1,663 $7K
87101 <1% 1,610 $7K
87046 <1% 1,444 $7K
88304 <1% 230 $7K
85245 <1% 536 $7K
87468 <1% 470 $7K
87469 <1% 468 $7K
87484 <1% 459 $7K
82952 <1% 3,297 $7K
85379 <1% 1,219 $7K
83014 <1% 1,734 $7K
87478 <1% 352 $7K
85240 <1% 648 $7K
85048 <1% 3,954 $6K
86335 <1% 447 $6K
86308 <1% 2,093 $6K
85246 <1% 467 $6K
81015 <1% 3,786 $6K
82232 <1% 721 $6K
86148 <1% 391 $6K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 10,056 $6K
87900 <1% 103 $6K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 619 $6K
87493 <1% 366 $6K
81243 <1% 163 $5K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 371 $5K
85306 <1% 526 $5K
86060 <1% 1,202 $5K
83835 <1% 524 $5K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 118 $5K
82679 <1% 360 $5K
86162 <1% 476 $5K
86231 <1% 582 $5K
82787 <1% 327 $5K
84482 <1% 621 $5K
86774 <1% 548 $5K
80357 <1% 8,914 $5K
82985 <1% 521 $4K
84446 <1% 570 $4K
82747 <1% 423 $4K
85007 <1% 2,444 $4K
84132 <1% 1,628 $4K
81401 <1% 53 $4K
82166 <1% 241 $4K
83992 <1% 2,794 $4K
36416 <1% 2,357 $4K
86256 <1% 577 $4K
84478 <1% 1,469 $4K
81244 <1% 53 $4K
83704 <1% 247 $3K
83718 <1% 776 $3K
81279 <1% 68 $3K
86666 <1% 153 $3K
86682 <1% 397 $3K
80352 <1% 2,050 $3K
87254 <1% 220 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 350 $3K
99199 Unlisted special service, procedure or report <1% 353 $3K
84163 <1% 308 $3K
83695 <1% 454 $3K
87207 <1% 1,037 $3K
86753 <1% 166 $3K
87497 <1% 114 $3K
87535 <1% 213 $3K
80375 <1% 2,002 $3K
82507 <1% 155 $3K
80377 <1% 2,256 $3K
85660 <1% 961 $3K
81508 <1% 88 $3K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 840 $2K
80183 <1% 344 $2K
81270 <1% 105 $2K
87486 <1% 69 $2K
87185 <1% 766 $2K
84300 <1% 841 $2K
86870 <1% 135 $2K
86702 <1% 583 $2K
88185 <1% 16 $2K
82085 <1% 449 $2K
83630 <1% 195 $2K
80364 <1% 3,924 $2K
86747 <1% 126 $2K
80156 <1% 267 $2K
80159 <1% 293 $2K
80342 <1% 360 $2K
85303 <1% 252 $2K
84295 <1% 1,069 $2K
80338 <1% 2,305 $2K
80332 <1% 624 $2K
80329 <1% 391 $2K
80367 <1% 1,880 $2K
81240 <1% 139 $2K
84255 <1% 128 $2K
83945 <1% 187 $1K
86337 <1% 125 $1K
86701 <1% 583 $1K
87906 <1% 25 $1K
81050 <1% 1,112 $1K
82340 <1% 382 $1K
82435 <1% 705 $1K
82365 <1% 151 $1K
83698 <1% 84 $1K
83825 <1% 112 $1K
80337 <1% 1,864 $1K
82374 <1% 531 $1K
84484 <1% 195 $975.70
81339 <1% 30 $973.71
80326 <1% 1,865 $972.05
82552 <1% 115 $923.08
84133 <1% 328 $873.74
80370 <1% 1,831 $857.24
83605 <1% 140 $853.67
83529 <1% 40 $853.09
80344 <1% 1,788 $815.55
84560 <1% 280 $806.07
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 85 $764.27
82705 <1% 241 $764.01
81219 <1% 30 $758.14
80185 <1% 96 $755.43
82180 <1% 140 $736.79
85247 <1% 51 $709.84
80333 <1% 1,794 $707.03
80165 <1% 112 $677.04
82175 <1% 55 $611.40
87521 Neg quan hep c or qual rna <1% 25 $607.89
87807 <1% 87 $599.19
84597 <1% 79 $580.56
84105 <1% 178 $579.31
83625 <1% 80 $555.92
82610 <1% 57 $543.02
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 44 $539.57
87328 <1% 73 $527.99
99001 <1% 283 $501.46
82104 <1% 59 $495.49
88189 <1% 14 $483.78
86648 <1% 52 $481.78
85049 <1% 209 $456.54
84080 <1% 67 $429.58
87107 <1% 75 $422.76
83527 <1% 79 $420.05
85300 <1% 66 $413.92
83930 <1% 253 $408.18
88184 <1% 16 $402.90
86340 <1% 46 $396.73
87040 <1% 70 $395.23
87220 <1% 232 $388.99
82384 <1% 28 $359.98
87581 <1% 12 $331.02
80340 <1% 1,713 $322.50
88341 <1% 12 $317.88
85598 <1% 39 $313.13
82397 <1% 52 $301.74
89055 <1% 117 $277.09
86790 <1% 17 $264.15
80330 <1% 1,726 $248.28
87467 <1% 29 $225.26
82681 <1% 13 $192.39
87109 <1% 18 $174.21
84392 <1% 58 $173.52
83935 <1% 51 $161.23
81400 <1% 13 $156.69
86692 <1% 14 $152.25
83986 <1% 3,764 $138.66
86663 <1% 13 $103.21
86041 <1% 13 $98.40
85651 <1% 43 $77.93
82575 <1% 15 $72.97
84311 <1% 3,698 $65.15
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 13 $30.49
85384 <1% 12 $29.48
81291 <1% 19 $26.95
87168 <1% 15 $10.40
81479 Unlisted molecular pathology procedure <1% 27 $3.94
87999 <1% 14 $0.03
3046F 0% 360 $0.00
3050F 0% 2,667 $0.00
3051F 0% 530 $0.00
WA047 0% 16 $0.00
80414 0% 32 $0.00
3048F 0% 5,101 $0.00
3052F 0% 309 $0.00
3049F 0% 3,474 $0.00
3044F 0% 6,055 $0.00
86001 0% 12 $0.00
WA081 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOWLES, CHARLES (SR. VICE PRESIDENT)
Parent organizationQUEST DIAGNOSTICS INCORPORATED
Same official

Other billing entities under BOWLES, CHARLES

Full network →
ProviderLocationPaid
Quest Diagnostics LLCMarlborough, MA$209.74M
Quest Diagnostics Clinical Laboratories INCSeattle, WA$109.23M
Quest Diagnostics Clinical Laboratories INCPortland, OR$21.85M
Quest Diagnostics of Pennsylvania INC.Buffalo, NY$20.20M
Quest Diagnostics Clinical Laboratories INCCollegeville, PA$12.52M
Solstas Lab Partners Group LLCGreensboro, NC$11.62M
Quest Diagnostics Incorporated MiFlint, MI$8.64M
Quest Diagnostics Clinical Laboratories INCTucker, GA$3.66M
Unilab CorporationWest Hills, CA$3.12M
Quest Diagnostics of Pennsylvania INC.Twinsburg, OH$2.56M
Quest Diagnostics Incorporated MDFalls Church, VA$936K
Quest Diagnostics LLCWallingford, CT$706K
Quest Diagnostics of Pennsylvania INC.North Syracuse, NY$492K
Solstas Lab Partners, LLCKnoxville, TN$455K
Quest Diagnostics Clinical Laboratories INCNorristown, PA$319K
Unilab CorporationSan Jose, CA$253K
Unilab CorporationOrange, CA$122K
Quest Diagnostics LLCStratford, CT$103K
Unilab CorporationBakersfield, CA$53K
Quest Diagnostics Clinical Laboratories INCHorsham, PA$48K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.